Shares of Exelixis (EXEL -13%) were hammered today after the biotech firm announced plans to...
Shares of Exelixis (EXEL -13%) were hammered today after the biotech firm announced plans to hold back-to-back public offerings. It plans to offer, subject to market conditions, 20M common shares and an aggregate $225M of convertible senior subordinated notes due in 2019.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Zacks.com (Fri, 9:29AM)
at Zacks.com (Mon, 2:30PM)
at Benzinga.com (Feb 5, 2015)
at CNBC.com (Dec 8, 2014)
at CNBC.com (Sep 29, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs